Scarica l'app Stockscreener
17.88
6.63%
-1.27
Precedente Chiudi:
$19.15
Aprire:
$19.3
Volume 24 ore:
118.96K
Relative Volume:
0.09
Capitalizzazione di mercato:
$176.27M
Reddito:
$88.50M
Utile/perdita netta:
$-35.27M
Rapporto P/E:
-5.4257
EPS:
-3.2954
Flusso di cassa netto:
$-23.70M
1 W Prestazione:
-4.79%
1M Prestazione:
+56.16%
6M Prestazione:
+138.34%
1 anno Prestazione:
+20.27%
Intervallo 1D:
$17.03
$20.20
Intervallo di 1 settimana:
$17.03
$20.21
Portata 52W:
$3.436
$20.21
Biodesix Inc Stock (BDSX) Company Profile
Nome
Biodesix Inc
Settore
Industria
Telefono
303-417-0500
Indirizzo
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
17.88 | 176.27M | 88.50M | -35.27M | -23.70M | -3.2954 |
|
TMO
Thermo Fisher Scientific Inc
|
464.37 | 172.51B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
187.32 | 132.46B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
573.82 | 45.69B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.51 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
286.57 | 28.11B | 3.17B | 642.63M | 516.49M | 10.77 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-27 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2025-05-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-07-26 | Iniziato | Craig Hallum | Buy |
| 2024-05-13 | Iniziato | TD Cowen | Buy |
| 2024-05-03 | Iniziato | Lake Street | Buy |
| 2021-11-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | Iniziato | BTIG Research | Buy |
| 2020-11-23 | Iniziato | Canaccord Genuity | Buy |
| 2020-11-23 | Iniziato | Morgan Stanley | Overweight |
| 2020-11-23 | Iniziato | William Blair | Outperform |
Mostra tutto
Biodesix Inc Borsa (BDSX) Ultime notizie
Biodesix Details Lung Test Momentum, 81% Gross Margin and Growth Plan at Barclays Conference - MarketBeat
Recap Report: What is the dividend yield of Biodesix IncNew Guidance & Accurate Trade Setup Notifications - baoquankhu1.vn
Biodesix Receives 'Moderate Buy' Rating from Analysts - National Today
Biodesix at Barclays Conference: Strategic Growth in Lung Cancer Diagnostics - Investing.com Canada
Biodesix Earnings Call Signals Growth With Caveats - TipRanks
Setup Watch: Is Biodesix Inc in a consolidation phase2026 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn
Biodesix, Inc. (NASDAQ:BDSX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Biodesix Details Lung Nodule Growth Plan, Primary Care Push at TD Cowen Healthcare Conference - MarketBeat
What analysts say about Biodesix Inc stock2025 Dividend Review & Daily Stock Momentum Reports - baoquankhu1.vn
How The Biodesix (BDSX) Investment Story Is Shifting After Guidance And New US$30 Target - Yahoo Finance
Wall Street experts predict that Biodesix (BDSX) may climb by 111.62%: Consider this information before making an investment decision - Bitget
Wall Street Analysts Think Biodesix (BDSX) Could Surge 111.62%: Read This Before Placing a Bet - Finviz
Are Medical Stocks Lagging Biodesix (BDSX) This Year? - Yahoo Finance
BDSX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Monashee Investment Management Cuts Biodesix Stake by 95% - National Today
Are healthcare stocks underperforming Biodesix (BDSX) so far this year? - Bitget
Canaccord reiterates Biodesix stock rating on strong Q4 results By Investing.com - Investing.com Canada
Canaccord reiterates Biodesix stock rating on strong Q4 results - Investing.com
Biodesix (BDSX) Q4 2025 Earnings Call Transcript - AOL.com
Monashee Investment Management LLC Cuts Holdings in Biodesix, Inc. $BDSX - MarketBeat
Q4 2025 Biodesix Inc Earnings Call Transcript - GuruFocus
William Blair Upgrades Biodesix (BDSX) - Nasdaq
William Blair Upgrades BDSX (Biodesix, Inc.) to Outperform Feb 2026 - Meyka
Biodesix (NASDAQ:BDSX) Announces Quarterly Earnings Results, Beats Estimates By $0.56 EPS - MarketBeat
William Blair Upgrades Biodesix (BDSX) to 'Outperform' | BDSX St - GuruFocus
Biodesix expects 2026 sales to crack $100M - BizWest
Biodesix, Inc. (BDSX) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
William Blair Upgrades Biodesix to Outperform From Market Perform - marketscreener.com
GSA Capital Partners LLP Has $365,000 Stake in Biodesix, Inc. $BDSX - MarketBeat
William Blair upgrades Biodesix stock rating on execution momentum By Investing.com - Investing.com Australia
Earnings call transcript: Biodesix Q4 2025 shows strong revenue growth and positive EBITDA By Investing.com - Investing.com South Africa
William Blair upgrades Biodesix stock rating on execution momentum - Investing.com Nigeria
Biodesix Inc (BDSX) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus
Biodesix, Inc. Q4 Loss Drops - Nasdaq
Biodesix Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Biodesix Q4 2025 shows strong revenue growth and positive EBITDA - Investing.com India
BDSX Projects 80% Gross Margin and Revenue Growth for FY26 - GuruFocus
Biodesix Inc (NASDAQ:BDSX) Reports Q4 2025 Earnings Beat and First Adjusted EBITDA Profitability - ChartMill
Biodesix Q4 Earnings Call Highlights - MarketBeat
Biodesix (BDSX) Surpasses Revenue Expectations in Q4 with 41% Gr - GuruFocus
Biodesix, Inc. (BDSX) Reports Q4 Loss, Beats Revenue Estimates - Nasdaq
Biodesix Inc. (BDSX) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Biodesix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights - TradingView
Biodesix (NASDAQ: BDSX) hits first positive EBITDA on 41% Q4 growth - Stock Titan
BRIEF-Biodesix Q4 Adjusted Operating Expenses USD 25.8 Million - TradingView
Biodesix, Inc. (BDSX) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
Earnings To Watch: Biodesix Inc (BDSX) Reports Q4 2025 Result - GuruFocus
Biodesix Inc Azioni (BDSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.34%
0.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):